However, around 15% of CML patients show deletion of the reciprocal ABL1-BCR fusion on the derivative chromosome 9 (der(9) deletion), often with loss of both chromosomes 9 and 22 sequences on either side of the breakpoint [2-4]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.